Consulting assignment at AstraZeneca, Gothenburg

WeQuel is looking, on behalf of our customer AstraZeneca, for an experienced Molecular Biologist with strong expertise in Next Generation Sequencing (NGS). This is a full-time consulting assignment starting October 1, 2025, until September 30, 2026.

About the role

You will join the NGS & Transcriptomics function within the Centre of Genomic Research and contribute to AstraZeneca’s ambition to become world-leading in oligonucleotide therapies. Your main responsibilities include:

• Performing lab-based NGS and molecular biology work to support drug discovery projects.
• Covering the full workflow: hypothesis generation, experimental design, RNA/DNA extraction, library preparation, sequencing, data handling, QC and troubleshooting.
• Collaborating closely with scientists, project leaders and data scientists across global teams.
• Contributing with supervision, mentorship, and development of new methods.

We are looking for

• Ph.D. or MSc with relevant experience in molecular biology.
• Proven hands-on expertise in advanced RNA sequencing techniques.
• Experience working with NGS platforms (e.g., Illumina, Oxford Nanopore).
• Strong communication skills and ability to thrive in cross-functional collaborations.

Desirable skills: experience with automation/liquid handling, LIMS, and oligonucleotide therapies (siRNA/ASO).

Why WeQuel?

WeQuel is a Scandinavian consultancy company specialized in Life Science and technology-driven industries. We value We are equal and People first – offering our consultants strong support, a collaborative network, and long-term relationships with leading companies.